Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy October 2021 142 - Subject
- Language
- ISSN
- 0753-3322